A private brief on Jersey's regulatory opportunity in health, longevity and biotech. Access requires a password.

For access, contact Grace Parker directly.

49°13′N 2°08′WDivergent by design.
05 · Timeline

The phasing, in six steps.

From a first States motion to a mature framework runs roughly a decade. The steps below are a plausible sequence, not a plan — every one depends on Government of Jersey, States Assembly and public-consultation processes.

Each step carries the legislative work, the regulator-capacity work and the physical-infrastructure work that would need to move together. Years are indicative. Three decision gates mark the moments where those strands need to align — not in lock-step, but close enough that one enables the next.

20262027202820292030203120322033203420352036
01 · Groundwork
02 · Framework office
03 · Research pathway
04 · Research opens
05 · Evidence review
06 · Mature framework
G1G2G3
Fig. 1 — Indicative phasing. Bars show the span of each step; G1–G3 mark the decision gates below.
01 — 2026 → 2027
Groundwork and first brief.
  • Regulatory-framework brief circulated (this document + supporting material)
  • Informal conversations with Government of Jersey and States members
  • Early conversations with the GMC and the UK Ministry of Justice’s Crown Dependencies team
  • Alignment with Digital Jersey, Jersey Business and Jersey Finance on the economic-diversification case
  • Consultation with the JCC on framework scope and capacity implications
  • Overdale IT specification shaped to support framework data needs
02 — 2027 → 2028
Framework office proposed.
  • States motion tabled proposing establishment of a Health Innovation Framework Office
  • Public consultation launched on framework scope (which domains, what governance)
  • Evidence thresholds for moving from research to authorised treatment published for consultation
  • Legislative drafting begins, with trial pathways and research licensing as the first-tranche priority
  • Framework-office funding case made to Treasury (private-capital co-investment model)
  • Specialist-personnel recruitment programme begins
03 — 2028 → 2029
Research pathway legislated.
  • First-tranche legislation debated and (target) passed: the Framework Office, trial and research-ethics pathways, and research licensing for controlled substances
  • Health Innovation Framework Office established, first head appointed
  • Clinical-outcome registry built and tested before the first research participant
  • Interoperability policy and common patient ID in place
  • Overdale hospital construction on final approach for opening
04 — 2029 → 2031
Research opens.
  • New Overdale hospital opens; old General Hospital vacated (target: ~2029–2030)
  • First research programmes open inside ethics-approved protocols: psilocybin, MDMA, longevity therapeutics and PGT-P
  • Services with established evidence begin under the framework: ketamine quality standards, advanced diagnostics, aesthetics accreditation, the cannabis supply chain
  • Second-tranche legislation (advanced therapeutics, diagnostics standards, aesthetics)
05 — 2031 → 2033
Evidence review.
  • First evidence reviews: results decide which research programmes can become authorised Jersey treatments, which continue, and which stop
  • Framework office publishes outcome data from services and research
  • Third-tranche legislation if needed (regulatory-body expansion, dispute mechanisms)
  • Framework office established as a permanent regulatory arm within Government of Jersey
06 — 2033 +
A mature framework.
  • First treatments authorised through the research route — the mid-2030s at the earliest
  • Framework mature and operating as one of Jersey's regulatory-industry pillars alongside finance, digital and legal
  • Continued refinement based on outcome data
Three decision gates

Where the strands need to meet.

Three moments where legislation, regulator capacity, evidence and physical infrastructure need to align.

G1 · 2027–2028

Framework office proposed and consultation open, including the evidence thresholds for turning research into treatment. Early work continues under existing law.

G2 · 2029–2030

Research pathway in force and outcome registry live as Overdale opens. Research programmes can open; services with established evidence start under the new rules.

G3 · 2032–2033

Evidence gate. Research results decide which programmes become authorised Jersey treatments and which stop.

A note on dependencies None of the milestones above can be committed to on this schedule. They depend on Government of Jersey, States Assembly and public-consultation processes. Framework activity that works under existing Jersey law can begin earlier; everything else waits on legislation. Treatments that start as research reach patients as authorised care only if the evidence supports it — so the dates for those are the least certain of all.